Search concepts
|
Selected Filters
|
- 100 - 150 out of 1,361 results
Search results
-
An Open-Label Randomized Active-Controlled Phase II Clinical Study to Assess the Efficacy and Safety of Afuresertib Plus Paclitaxel Versus Paclitaxel in Patients with Platinum-ResistantOvarian Cancer
Kamat, A. A., Alaniz, A., Darcourt, J., Singh, M., Suri, A. & Zaid, T.
3/15/21 → 3/14/46
Project: Non Profit
-
A novel 3D cell culture human uterine contractility assay for high-throughput screening and mechanistic evaluation of tocolytic substances
9/22/14 → 8/31/16
Project: Federal Funding Agencies
-
A Novel eFace System to Prevent the Risks of Facial Distortion after CMF Surgery
Natl Inst of Dental and Craniofacial Res
4/1/16 → 3/31/19
Project: Federal Funding Agencies
-
A Novel eFace System to Prevent the Risks of Facial Distortion after CMF Surgery
Natl Inst of Dental and Craniofacial Res
5/1/13 → 3/31/16
Project: Federal Funding Agencies
-
A NOVEL HISTONE MODIFICATION MEDIATES DNA ACCESSIBILITY: ROLE OF INOS
1/1/20 → 12/31/21
Project: Non Profit
-
A Novel Imaging Analysis Platform for Patients with Craniomaxillofacial Deformities
Natl Inst of Dental and Craniofacial Res
2/1/16 → 1/31/23
Project: Federal Funding Agencies
-
A novel imaging informatics platform for craniomaxillofacial surgery
Natl Inst of Dental and Craniofacial Res
9/7/11 → 8/31/15
Project: Federal Funding Agencies
-
A Novel M2 Lipogenic Macrophage Associated with Fracture Callus are Altered in Type 2 Diabetes
6/1/21 → 5/31/23
Project: Federal Funding Agencies
-
A Novel Multi-Antigen Vaccine (TNBCvax) to Prevent Triple Negative Breast Cancer
9/16/21 → 3/15/23
Project: Federal Funding Agencies
-
A novel nanochannel system for sustained delivery of Tenofovir Alafenamide Fumarate and Emtricitabine for HIV pre-exposure prophylaxis
6/20/16 → 5/31/22
Project: Federal Funding Agencies
-
A Novel Organoid Platform to Modulate Human Neural Networks Integrated with Glioblastoma Stem Cells
Krencik, R. C. & Rostomily, R. C.
8/31/20 → 8/30/23
Project: State
-
-
A Novel Pathway Involving ATM PP1 and I-2
Natl Inst of Environmental Health Sci
1/28/10 → 3/31/14
Project: Federal Funding Agencies
-
A Novel Role for MAGI1 in regulating non-canonical LATS signaling and atherosclerotic plaque formation
1/1/18 → 2/28/23
Project: Federal Funding Agencies
-
A novel role for polycomb group proteins in androgen signaling and prostate cancer.
5/20/13 → 6/30/18
Project: Non Profit
-
A novel T-cell subset able to kill relapsed cancers
7/1/16 → 6/30/22
Project: Federal Funding Agencies
-
A novel tool in high- dimensional single-cell space to predict neurotoxicity of CAR T cell therapies
8/1/21 → 7/31/26
Project: Federal Funding Agencies
-
A novel treatment strategy to target the underlying causes of both the wet and dry forms of AMD
7/1/18 → 6/30/21
Project: Non Profit
-
Antigen specificity, suppressive mechanism & regulation of CD4+ regulatory T cell
2/17/12 → 7/31/13
Project: Federal Funding Agencies
-
-
-
-
AOCT - COVID-19 Plasma Donation
Castillo, B., Chen, J. & Leveque, C.
3/26/20 → …
Project: Clinical Trial
-
-
-
-
-
APEX1 is a critical cytosolic molecule to sense self DNAs in autoimmune diseases
5/1/14 → 4/30/16
Project: Federal Funding Agencies
-
A Phase 0, Investigator Initiated Study, Evaluating the Impact of Omega 3 Free Fatty Acid Supplementation on Aromatase in Obese Subjects (CTMS# 15-2100)
Niravath, P. A., Chang, J. C. & Darcourt, J.
12/1/16 → 11/30/18
Project: Federal Funding Agencies
-
A Phase 1a/b Dose-Escalation Study Followed by Expansion Cohorts of NGM120, a GFRAL Antagonist Monoclonal Antibody Blocking GDF15 Signaling, in Subjects With Advanced Solid Tumors and Pancreatic Cancer Using Combination Therapy
Singh, M., Abdelrahim, M., Beinart, G. & Heyne, K.
5/18/20 → …
Project: Clinical Trial
-
A Phase 1b Study Evaluating the Safety, Tolerability, and Pharmacokinetics of Bemarituzumab in Combination with Other Anti-Cancer Therapies in Subjects with Previously Untreated Advanced Gastric or Gastroesophageal Junction Cancer with FGFR2b Overexpression (FORTITUDE-103)
Abdelrahim, M., Bernicker, E. H., Heyne, K., Singh, M. & Zhang, J.
Project: Clinical Trial
-
A Phase 2, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled Study Evaluating the Safety and Efficacy of Semaglutide, and the Fixed-Dose Combination of Cilofexor and Firsocostat, Alone and in Combination, in Subjects With Compensated Cirrhosis (F4) Due to Nonalcoholic Steatohepatitis (NASH)
Victor, III, D. W. & Kodali, S.
10/11/22 → …
Project: Clinical Trial
-
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of K0706 in Subjects With Early Parkinson's Disease
10/22/19 → …
Project: Clinical Trial
-
A Phase 2a, Double-Blind, Randomized, Active Controlled, Parallel Group Study Evaluating the Efficacy, Safety, and Tolerability of Bezafibrate Administered in Combination with Obeticholic Acid in Subjects with Primary Biliary Cholangitis
Victor, III, D. W. & Kodali, S.
10/14/22 → …
Project: Clinical Trial
-
A PHASE 2 STUDY OF FUTIBATINIB IN PATIENTS WITH SPECIFIC FGFR ABERRATIONS
Abdelrahim, M., Heyne, K. & Singh, M.
Project: Clinical Trial
-
A Phase 3, Multicenter, Randomized, Controlled, Open-Label, Assessor-Blinded Study to Evaluate the Efficacy and Safety of Inhaled Isoflurane Delivered via the Sedaconda ACD-S Compared to Intravenous Propofol for Sedation of Mechanically Ventilated Intensive Care Unit Adult Patients (INSPiRE-ICU1)
Faisal, H., Dhala, A., Masud, F. N., Mobley, C. M. & Moore, L. W.
Project: Clinical Trial
-
A Phase 3, Multicenter, Randomized, Open-Label, Active-Controlled Study of Trastuzumab Deruxtecan (T-DXd) Versus Trastuzumab Emtansine (T-DM1) in Participants With High-Risk HER2-Positive Primary Breast Cancer Who Have Residual Invasive Disease in Breast
Chang, J. C. & Niravath, P. A.
7/30/21 → …
Project: Clinical Trial